Gene mutation status in circulating tumor DNA (ctDNA) and first-line FOLFOXIRI plus bevacizumab (bev) in metastatic colorectal cancer (mCRC) harboring RAS mutation.
暂无分享，去创建一个
H. Lenz | M. Takeuchi | K. Danenberg | P. Danenberg | W. Ichikawa | T. Sekikawa | M. Fujii | K. Ishigure | M. Shiozawa | Y. Sunakawa | T. Terazawa | H. Satake | A. Takagane | C. Tanaka | M. Kataoka | J. Usher | Y. Jaimes | Y. Miyamoto | M. Nakamura | T. Watanabe